Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines

15Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.

Abstract

To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some have proposed accelerating SARS-CoV-2 vaccine development through controlled human infection (or 'challenge') trials. These trials would involve the deliberate exposure of relatively few young, healthy volunteers to SARS-CoV-2. We defend this proposal against the charge that there is still too much uncertainty surrounding the risks of COVID-19 to responsibly run such a trial.

Cite

CITATION STYLE

APA

Steel, R., Buchak, L., & Eyal, N. (2020). Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines. Journal of Medical Ethics, 46(12), 808–812. https://doi.org/10.1136/medethics-2020-106501

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free